Document is current
Any future updates will be listed below
-
Authors
Zhang, Huina
Liu, Peng
Deng, Yaxuan
Wu, Li
Fan, Orion
Cui, Yanling
Zhang, Chunxue
Zhu, Wenmin
Sun, Yi Eve
Lin, Chuwen
Wang, Congrong https://orcid.org/0000-0002-8645-1114
-
Funding
Funding for this research was provided by:
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2025ZD0549900)
the Natural Science Foundation of China (82070913)
Shanghai Science and Technology Development Funds (22410713200)
Key discipline project of Hongkou District Health Commission (HKLCFC202403)
the Fund of Shanghai Hongkou District Health Committee (Hong Wei 2303-06)
Research fund from Shanghai Fourth People’s Hospital (sykyqd01801，SY-XKZT-2021-1001)
- License Information
-
More Information
Article History
Received: 23 September 2024
Accepted: 4 December 2025
First Online: 13 December 2025
Declarations
:
: The hUC-MSCs were acquired from the Translational Medical Center for Stem Cell Therapy at Shanghai East Hospital. The experimental protocol received approval from the Ethics Committee of Shanghai East Hospital (Approved project: Preparation and banking of clinical-grade human umbilical cord and cord blood stem cells, Approval No. Tilinshen-2017-001, Date of approval: Dec 15, 2017). Umbilical cord guardians provided written informed consent for the use of samples. All relevant procedures involving animal experiments were approved by the Animal Welfare Ethics Committee of Shanghai Sixth People’s Hospital Affiliated with Shanghai Jiao Tong University School of Medicine (Approved project: Human umbilical cord-derived mesenchymal stem cells ameliorate non-alcoholic fatty liver disease via activating TFEB-mediated autophagy, Approval No. DWLL2019-0026, Date of approval: Sep 20, 2024).
: Not applicable.
: The authors declare no competing interests.
